The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
The expanding role of pharmacovigilance and risk management
A profound and accelerated transformation of the Pharmacovigilance world is happening, due to several key drivers. The absolute necessity to ensure that patients can benefit from an early access to new drugs, while ensuring an optimal identification and management of risks is vital.
The regulatory world is rapidly evolving to shorten the review and approval process, moving toward more conditional approvals with restricted and controlled drug use. The field of combination products, with the limitless possibilities of smartphones, device technology, sensors and drug delivery systems is exploding. The ability to access massive datasets across different systems and populations is disrupting the existing approaches to data mining and pharmacoepidemiology.
The customization of benefit-risk at the individual level brings patient engagement activities and risk communication to a totally different way of thinking about benefit-risk and risk communication. In the meantime, the ever increasing dis-harmonization of safety requirements across regions and countries obliges pharmacovigilance organizations to constantly look for innovation, productivity and performance gains. These are some of the significant but very exciting challenges that makes pharmacovigilance such a fascinating domain, more than ever. The ability to understand the current trends and to brainstorm with key opinion leaders and colleagues are critical to preparing our minds and practices to this changing world.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Patient experience at the forefront as the UAE healthcare market continues to grow
1st GCC Patient Experience Summit (18 - 19 September 2017) organized by Fleming.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.